EUSA Pharma
Karan Kanhai, MD, PhD, is a seasoned medical professional with extensive experience in medical affairs, particularly within the fields of haemato-oncology and rare diseases. Currently serving as Senior Director and Global Medical Lead at EUSA Pharma/now RECORDATI Rare Disease since January 2019, Karan has previously held notable positions including Senior Director of Medical Affairs at BioMarin Pharmaceutical Inc., Medical Director of Oncology at Astellas Pharma Europe, and various roles at Astellas Pharma and sanofi-aventis. Karan began a career in medicine after earning an MD from Erasmus University Rotterdam, followed by a PhD in Medicine from the same institution. Early professional experience includes roles as an Occupational Health Physician and Resident in General Surgery, alongside research in medicine.
This person is not in any offices
EUSA Pharma
1 followers
We are committed to transforming the lives of people affected by cancer or rare disease, globally. We continuously strive to uncover opportunities which address gaps across adult and paediatric care. Helping the people with few or no options available is at the heart of everything we do. EUSA Pharma is part of Recordati Rare Diseases (recordatirarediseases.com), the business unit dedicated to rare disease in the Recordati group. Recordati has a total staff of more than 4,300, dedicated to the research, development, manufacturing and marketing of pharmaceuticals. More information can be found in the press release: https://www.recordati.com/resources/Pubblicazione/___58a6bc05f57c4861aae203c930cd1682_/eusa-closing-pr.pdf We see a need. We work together. We don’t give up.